Global Porcine Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Porcine Vaccines market size was valued at US$ 1315.7 million in 2023. With growing demand in downstream market, the Porcine Vaccines is forecast to a readjusted size of US$ 2077.5 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Porcine Vaccines market. Porcine Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Porcine Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Porcine Vaccines market.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The report on Porcine Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Porcine Vaccines market. It may include historical data, market segmentation by Type (e.g., CSF Vaccines, FMD Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Porcine Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Porcine Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Porcine Vaccines industry. This include advancements in Porcine Vaccines technology, Porcine Vaccines new entrants, Porcine Vaccines new investment, and other innovations that are shaping the future of Porcine Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Porcine Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Porcine Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Porcine Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Porcine Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Porcine Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Porcine Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Porcine Vaccines market.
Market Segmentation:
Porcine Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Porcine Vaccines market?
What factors are driving Porcine Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Porcine Vaccines market opportunities vary by end market size?
How does Porcine Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Porcine Vaccines market size was valued at US$ 1315.7 million in 2023. With growing demand in downstream market, the Porcine Vaccines is forecast to a readjusted size of US$ 2077.5 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Porcine Vaccines market. Porcine Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Porcine Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Porcine Vaccines market.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The report on Porcine Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Porcine Vaccines market. It may include historical data, market segmentation by Type (e.g., CSF Vaccines, FMD Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Porcine Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Porcine Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Porcine Vaccines industry. This include advancements in Porcine Vaccines technology, Porcine Vaccines new entrants, Porcine Vaccines new investment, and other innovations that are shaping the future of Porcine Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Porcine Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Porcine Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Porcine Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Porcine Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Porcine Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Porcine Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Porcine Vaccines market.
Market Segmentation:
Porcine Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Other
- Government Tender
- Market Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
What is the 10-year outlook for the global Porcine Vaccines market?
What factors are driving Porcine Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Porcine Vaccines market opportunities vary by end market size?
How does Porcine Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Porcine Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Porcine Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Porcine Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Porcine Vaccines Segment by Type
2.2.1 CSF Vaccines
2.2.2 FMD Vaccines
2.2.3 Porcine Circovirus Vaccines
2.2.4 PRRS Vaccines
2.2.5 Other
2.3 Porcine Vaccines Sales by Type
2.3.1 Global Porcine Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Porcine Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Porcine Vaccines Sale Price by Type (2019-2024)
2.4 Porcine Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Porcine Vaccines Sales by Application
2.5.1 Global Porcine Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Porcine Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Porcine Vaccines Sale Price by Application (2019-2024)
3 GLOBAL PORCINE VACCINES BY COMPANY
3.1 Global Porcine Vaccines Breakdown Data by Company
3.1.1 Global Porcine Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Porcine Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Porcine Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Porcine Vaccines Revenue by Company (2019-2024)
3.2.2 Global Porcine Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Porcine Vaccines Sale Price by Company
3.4 Key Manufacturers Porcine Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Porcine Vaccines Product Location Distribution
3.4.2 Players Porcine Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PORCINE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Porcine Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Porcine Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Porcine Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Porcine Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Porcine Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Porcine Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Porcine Vaccines Sales Growth
4.4 APAC Porcine Vaccines Sales Growth
4.5 Europe Porcine Vaccines Sales Growth
4.6 Middle East & Africa Porcine Vaccines Sales Growth
5 AMERICAS
5.1 Americas Porcine Vaccines Sales by Country
5.1.1 Americas Porcine Vaccines Sales by Country (2019-2024)
5.1.2 Americas Porcine Vaccines Revenue by Country (2019-2024)
5.2 Americas Porcine Vaccines Sales by Type
5.3 Americas Porcine Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Porcine Vaccines Sales by Region
6.1.1 APAC Porcine Vaccines Sales by Region (2019-2024)
6.1.2 APAC Porcine Vaccines Revenue by Region (2019-2024)
6.2 APAC Porcine Vaccines Sales by Type
6.3 APAC Porcine Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Porcine Vaccines by Country
7.1.1 Europe Porcine Vaccines Sales by Country (2019-2024)
7.1.2 Europe Porcine Vaccines Revenue by Country (2019-2024)
7.2 Europe Porcine Vaccines Sales by Type
7.3 Europe Porcine Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Porcine Vaccines by Country
8.1.1 Middle East & Africa Porcine Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Porcine Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Porcine Vaccines Sales by Type
8.3 Middle East & Africa Porcine Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Porcine Vaccines
10.3 Manufacturing Process Analysis of Porcine Vaccines
10.4 Industry Chain Structure of Porcine Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Porcine Vaccines Distributors
11.3 Porcine Vaccines Customer
12 WORLD FORECAST REVIEW FOR PORCINE VACCINES BY GEOGRAPHIC REGION
12.1 Global Porcine Vaccines Market Size Forecast by Region
12.1.1 Global Porcine Vaccines Forecast by Region (2025-2030)
12.1.2 Global Porcine Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Porcine Vaccines Forecast by Type
12.7 Global Porcine Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Porcine Vaccines Product Portfolios and Specifications
13.1.3 Merck Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Porcine Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Jinyu Bio-Technology
13.3.1 Jinyu Bio-Technology Company Information
13.3.2 Jinyu Bio-Technology Porcine Vaccines Product Portfolios and Specifications
13.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jinyu Bio-Technology Main Business Overview
13.3.5 Jinyu Bio-Technology Latest Developments
13.4 CAHIC
13.4.1 CAHIC Company Information
13.4.2 CAHIC Porcine Vaccines Product Portfolios and Specifications
13.4.3 CAHIC Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CAHIC Main Business Overview
13.4.5 CAHIC Latest Developments
13.5 Tecon
13.5.1 Tecon Company Information
13.5.2 Tecon Porcine Vaccines Product Portfolios and Specifications
13.5.3 Tecon Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tecon Main Business Overview
13.5.5 Tecon Latest Developments
13.6 Zoetis
13.6.1 Zoetis Company Information
13.6.2 Zoetis Porcine Vaccines Product Portfolios and Specifications
13.6.3 Zoetis Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zoetis Main Business Overview
13.6.5 Zoetis Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Porcine Vaccines Product Portfolios and Specifications
13.7.3 Ceva Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Hile Bio
13.8.1 Hile Bio Company Information
13.8.2 Hile Bio Porcine Vaccines Product Portfolios and Specifications
13.8.3 Hile Bio Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hile Bio Main Business Overview
13.8.5 Hile Bio Latest Developments
13.9 Chopper Biology
13.9.1 Chopper Biology Company Information
13.9.2 Chopper Biology Porcine Vaccines Product Portfolios and Specifications
13.9.3 Chopper Biology Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Chopper Biology Main Business Overview
13.9.5 Chopper Biology Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Porcine Vaccines Product Portfolios and Specifications
13.10.3 WINSUN Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Hipra
13.11.1 Hipra Company Information
13.11.2 Hipra Porcine Vaccines Product Portfolios and Specifications
13.11.3 Hipra Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hipra Main Business Overview
13.11.5 Hipra Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Porcine Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 DHN
13.13.1 DHN Company Information
13.13.2 DHN Porcine Vaccines Product Portfolios and Specifications
13.13.3 DHN Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 DHN Main Business Overview
13.13.5 DHN Latest Developments
13.14 CAVAC
13.14.1 CAVAC Company Information
13.14.2 CAVAC Porcine Vaccines Product Portfolios and Specifications
13.14.3 CAVAC Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 CAVAC Main Business Overview
13.14.5 CAVAC Latest Developments
13.15 Virbac
13.15.1 Virbac Company Information
13.15.2 Virbac Porcine Vaccines Product Portfolios and Specifications
13.15.3 Virbac Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Virbac Main Business Overview
13.15.5 Virbac Latest Developments
13.16 HVRI
13.16.1 HVRI Company Information
13.16.2 HVRI Porcine Vaccines Product Portfolios and Specifications
13.16.3 HVRI Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 HVRI Main Business Overview
13.16.5 HVRI Latest Developments
13.17 Bioveta
13.17.1 Bioveta Company Information
13.17.2 Bioveta Porcine Vaccines Product Portfolios and Specifications
13.17.3 Bioveta Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Bioveta Main Business Overview
13.17.5 Bioveta Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Porcine Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Porcine Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Porcine Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Porcine Vaccines Segment by Type
2.2.1 CSF Vaccines
2.2.2 FMD Vaccines
2.2.3 Porcine Circovirus Vaccines
2.2.4 PRRS Vaccines
2.2.5 Other
2.3 Porcine Vaccines Sales by Type
2.3.1 Global Porcine Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Porcine Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Porcine Vaccines Sale Price by Type (2019-2024)
2.4 Porcine Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Porcine Vaccines Sales by Application
2.5.1 Global Porcine Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Porcine Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Porcine Vaccines Sale Price by Application (2019-2024)
3 GLOBAL PORCINE VACCINES BY COMPANY
3.1 Global Porcine Vaccines Breakdown Data by Company
3.1.1 Global Porcine Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Porcine Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Porcine Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Porcine Vaccines Revenue by Company (2019-2024)
3.2.2 Global Porcine Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Porcine Vaccines Sale Price by Company
3.4 Key Manufacturers Porcine Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Porcine Vaccines Product Location Distribution
3.4.2 Players Porcine Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PORCINE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Porcine Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Porcine Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Porcine Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Porcine Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Porcine Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Porcine Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Porcine Vaccines Sales Growth
4.4 APAC Porcine Vaccines Sales Growth
4.5 Europe Porcine Vaccines Sales Growth
4.6 Middle East & Africa Porcine Vaccines Sales Growth
5 AMERICAS
5.1 Americas Porcine Vaccines Sales by Country
5.1.1 Americas Porcine Vaccines Sales by Country (2019-2024)
5.1.2 Americas Porcine Vaccines Revenue by Country (2019-2024)
5.2 Americas Porcine Vaccines Sales by Type
5.3 Americas Porcine Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Porcine Vaccines Sales by Region
6.1.1 APAC Porcine Vaccines Sales by Region (2019-2024)
6.1.2 APAC Porcine Vaccines Revenue by Region (2019-2024)
6.2 APAC Porcine Vaccines Sales by Type
6.3 APAC Porcine Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Porcine Vaccines by Country
7.1.1 Europe Porcine Vaccines Sales by Country (2019-2024)
7.1.2 Europe Porcine Vaccines Revenue by Country (2019-2024)
7.2 Europe Porcine Vaccines Sales by Type
7.3 Europe Porcine Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Porcine Vaccines by Country
8.1.1 Middle East & Africa Porcine Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Porcine Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Porcine Vaccines Sales by Type
8.3 Middle East & Africa Porcine Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Porcine Vaccines
10.3 Manufacturing Process Analysis of Porcine Vaccines
10.4 Industry Chain Structure of Porcine Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Porcine Vaccines Distributors
11.3 Porcine Vaccines Customer
12 WORLD FORECAST REVIEW FOR PORCINE VACCINES BY GEOGRAPHIC REGION
12.1 Global Porcine Vaccines Market Size Forecast by Region
12.1.1 Global Porcine Vaccines Forecast by Region (2025-2030)
12.1.2 Global Porcine Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Porcine Vaccines Forecast by Type
12.7 Global Porcine Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Porcine Vaccines Product Portfolios and Specifications
13.1.3 Merck Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Porcine Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Jinyu Bio-Technology
13.3.1 Jinyu Bio-Technology Company Information
13.3.2 Jinyu Bio-Technology Porcine Vaccines Product Portfolios and Specifications
13.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jinyu Bio-Technology Main Business Overview
13.3.5 Jinyu Bio-Technology Latest Developments
13.4 CAHIC
13.4.1 CAHIC Company Information
13.4.2 CAHIC Porcine Vaccines Product Portfolios and Specifications
13.4.3 CAHIC Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CAHIC Main Business Overview
13.4.5 CAHIC Latest Developments
13.5 Tecon
13.5.1 Tecon Company Information
13.5.2 Tecon Porcine Vaccines Product Portfolios and Specifications
13.5.3 Tecon Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tecon Main Business Overview
13.5.5 Tecon Latest Developments
13.6 Zoetis
13.6.1 Zoetis Company Information
13.6.2 Zoetis Porcine Vaccines Product Portfolios and Specifications
13.6.3 Zoetis Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zoetis Main Business Overview
13.6.5 Zoetis Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Porcine Vaccines Product Portfolios and Specifications
13.7.3 Ceva Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Hile Bio
13.8.1 Hile Bio Company Information
13.8.2 Hile Bio Porcine Vaccines Product Portfolios and Specifications
13.8.3 Hile Bio Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hile Bio Main Business Overview
13.8.5 Hile Bio Latest Developments
13.9 Chopper Biology
13.9.1 Chopper Biology Company Information
13.9.2 Chopper Biology Porcine Vaccines Product Portfolios and Specifications
13.9.3 Chopper Biology Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Chopper Biology Main Business Overview
13.9.5 Chopper Biology Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Porcine Vaccines Product Portfolios and Specifications
13.10.3 WINSUN Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Hipra
13.11.1 Hipra Company Information
13.11.2 Hipra Porcine Vaccines Product Portfolios and Specifications
13.11.3 Hipra Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hipra Main Business Overview
13.11.5 Hipra Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Porcine Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 DHN
13.13.1 DHN Company Information
13.13.2 DHN Porcine Vaccines Product Portfolios and Specifications
13.13.3 DHN Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 DHN Main Business Overview
13.13.5 DHN Latest Developments
13.14 CAVAC
13.14.1 CAVAC Company Information
13.14.2 CAVAC Porcine Vaccines Product Portfolios and Specifications
13.14.3 CAVAC Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 CAVAC Main Business Overview
13.14.5 CAVAC Latest Developments
13.15 Virbac
13.15.1 Virbac Company Information
13.15.2 Virbac Porcine Vaccines Product Portfolios and Specifications
13.15.3 Virbac Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Virbac Main Business Overview
13.15.5 Virbac Latest Developments
13.16 HVRI
13.16.1 HVRI Company Information
13.16.2 HVRI Porcine Vaccines Product Portfolios and Specifications
13.16.3 HVRI Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 HVRI Main Business Overview
13.16.5 HVRI Latest Developments
13.17 Bioveta
13.17.1 Bioveta Company Information
13.17.2 Bioveta Porcine Vaccines Product Portfolios and Specifications
13.17.3 Bioveta Porcine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Bioveta Main Business Overview
13.17.5 Bioveta Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Porcine Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Porcine Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CSF Vaccines
Table 4. Major Players of FMD Vaccines
Table 5. Major Players of Porcine Circovirus Vaccines
Table 6. Major Players of PRRS Vaccines
Table 7. Major Players of Other
Table 8. Global Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 9. Global Porcine Vaccines Sales Market Share by Type (2019-2024)
Table 10. Global Porcine Vaccines Revenue by Type (2019-2024) & ($ million)
Table 11. Global Porcine Vaccines Revenue Market Share by Type (2019-2024)
Table 12. Global Porcine Vaccines Sale Price by Type (2019-2024) & (USD/K Unit)
Table 13. Global Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 14. Global Porcine Vaccines Sales Market Share by Application (2019-2024)
Table 15. Global Porcine Vaccines Revenue by Application (2019-2024)
Table 16. Global Porcine Vaccines Revenue Market Share by Application (2019-2024)
Table 17. Global Porcine Vaccines Sale Price by Application (2019-2024) & (USD/K Unit)
Table 18. Global Porcine Vaccines Sales by Company (2019-2024) & (M Units)
Table 19. Global Porcine Vaccines Sales Market Share by Company (2019-2024)
Table 20. Global Porcine Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Porcine Vaccines Revenue Market Share by Company (2019-2024)
Table 22. Global Porcine Vaccines Sale Price by Company (2019-2024) & (USD/K Unit)
Table 23. Key Manufacturers Porcine Vaccines Producing Area Distribution and Sales Area
Table 24. Players Porcine Vaccines Products Offered
Table 25. Porcine Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Porcine Vaccines Sales by Geographic Region (2019-2024) & (M Units)
Table 29. Global Porcine Vaccines Sales Market Share Geographic Region (2019-2024)
Table 30. Global Porcine Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Porcine Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Porcine Vaccines Sales by Country/Region (2019-2024) & (M Units)
Table 33. Global Porcine Vaccines Sales Market Share by Country/Region (2019-2024)
Table 34. Global Porcine Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Porcine Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Porcine Vaccines Sales by Country (2019-2024) & (M Units)
Table 37. Americas Porcine Vaccines Sales Market Share by Country (2019-2024)
Table 38. Americas Porcine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Porcine Vaccines Revenue Market Share by Country (2019-2024)
Table 40. Americas Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 41. Americas Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 42. APAC Porcine Vaccines Sales by Region (2019-2024) & (M Units)
Table 43. APAC Porcine Vaccines Sales Market Share by Region (2019-2024)
Table 44. APAC Porcine Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Porcine Vaccines Revenue Market Share by Region (2019-2024)
Table 46. APAC Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 47. APAC Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 48. Europe Porcine Vaccines Sales by Country (2019-2024) & (M Units)
Table 49. Europe Porcine Vaccines Sales Market Share by Country (2019-2024)
Table 50. Europe Porcine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Porcine Vaccines Revenue Market Share by Country (2019-2024)
Table 52. Europe Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 53. Europe Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 54. Middle East & Africa Porcine Vaccines Sales by Country (2019-2024) & (M Units)
Table 55. Middle East & Africa Porcine Vaccines Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Porcine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Porcine Vaccines Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 59. Middle East & Africa Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 60. Key Market Drivers & Growth Opportunities of Porcine Vaccines
Table 61. Key Market Challenges & Risks of Porcine Vaccines
Table 62. Key Industry Trends of Porcine Vaccines
Table 63. Porcine Vaccines Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Porcine Vaccines Distributors List
Table 66. Porcine Vaccines Customer List
Table 67. Global Porcine Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 68. Global Porcine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Porcine Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 70. Americas Porcine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Porcine Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 72. APAC Porcine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Porcine Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 74. Europe Porcine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Porcine Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 76. Middle East & Africa Porcine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Porcine Vaccines Sales Forecast by Type (2025-2030) & (M Units)
Table 78. Global Porcine Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Porcine Vaccines Sales Forecast by Application (2025-2030) & (M Units)
Table 80. Global Porcine Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Merck Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Porcine Vaccines Product Portfolios and Specifications
Table 83. Merck Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. Boehringer Ingelheim Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. Boehringer Ingelheim Porcine Vaccines Product Portfolios and Specifications
Table 88. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Jinyu Bio-Technology Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Jinyu Bio-Technology Porcine Vaccines Product Portfolios and Specifications
Table 93. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 94. Jinyu Bio-Technology Main Business
Table 95. Jinyu Bio-Technology Latest Developments
Table 96. CAHIC Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. CAHIC Porcine Vaccines Product Portfolios and Specifications
Table 98. CAHIC Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 99. CAHIC Main Business
Table 100. CAHIC Latest Developments
Table 101. Tecon Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Tecon Porcine Vaccines Product Portfolios and Specifications
Table 103. Tecon Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 104. Tecon Main Business
Table 105. Tecon Latest Developments
Table 106. Zoetis Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Zoetis Porcine Vaccines Product Portfolios and Specifications
Table 108. Zoetis Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 109. Zoetis Main Business
Table 110. Zoetis Latest Developments
Table 111. Ceva Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Ceva Porcine Vaccines Product Portfolios and Specifications
Table 113. Ceva Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 114. Ceva Main Business
Table 115. Ceva Latest Developments
Table 116. Hile Bio Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Hile Bio Porcine Vaccines Product Portfolios and Specifications
Table 118. Hile Bio Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 119. Hile Bio Main Business
Table 120. Hile Bio Latest Developments
Table 121. Chopper Biology Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. Chopper Biology Porcine Vaccines Product Portfolios and Specifications
Table 123. Chopper Biology Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 124. Chopper Biology Main Business
Table 125. Chopper Biology Latest Developments
Table 126. WINSUN Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. WINSUN Porcine Vaccines Product Portfolios and Specifications
Table 128. WINSUN Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 129. WINSUN Main Business
Table 130. WINSUN Latest Developments
Table 131. Hipra Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Hipra Porcine Vaccines Product Portfolios and Specifications
Table 133. Hipra Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 134. Hipra Main Business
Table 135. Hipra Latest Developments
Table 136. Ringpu Biology Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. Ringpu Biology Porcine Vaccines Product Portfolios and Specifications
Table 138. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 139. Ringpu Biology Main Business
Table 140. Ringpu Biology Latest Developments
Table 141. DHN Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. DHN Porcine Vaccines Product Portfolios and Specifications
Table 143. DHN Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 144. DHN Main Business
Table 145. DHN Latest Developments
Table 146. CAVAC Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. CAVAC Porcine Vaccines Product Portfolios and Specifications
Table 148. CAVAC Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 149. CAVAC Main Business
Table 150. CAVAC Latest Developments
Table 151. Virbac Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. Virbac Porcine Vaccines Product Portfolios and Specifications
Table 153. Virbac Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 154. Virbac Main Business
Table 155. Virbac Latest Developments
Table 156. HVRI Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. HVRI Porcine Vaccines Product Portfolios and Specifications
Table 158. HVRI Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 159. HVRI Main Business
Table 160. HVRI Latest Developments
Table 161. Bioveta Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. Bioveta Porcine Vaccines Product Portfolios and Specifications
Table 163. Bioveta Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 164. Bioveta Main Business
Table 165. Bioveta Latest Developments
Table 1. Porcine Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Porcine Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CSF Vaccines
Table 4. Major Players of FMD Vaccines
Table 5. Major Players of Porcine Circovirus Vaccines
Table 6. Major Players of PRRS Vaccines
Table 7. Major Players of Other
Table 8. Global Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 9. Global Porcine Vaccines Sales Market Share by Type (2019-2024)
Table 10. Global Porcine Vaccines Revenue by Type (2019-2024) & ($ million)
Table 11. Global Porcine Vaccines Revenue Market Share by Type (2019-2024)
Table 12. Global Porcine Vaccines Sale Price by Type (2019-2024) & (USD/K Unit)
Table 13. Global Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 14. Global Porcine Vaccines Sales Market Share by Application (2019-2024)
Table 15. Global Porcine Vaccines Revenue by Application (2019-2024)
Table 16. Global Porcine Vaccines Revenue Market Share by Application (2019-2024)
Table 17. Global Porcine Vaccines Sale Price by Application (2019-2024) & (USD/K Unit)
Table 18. Global Porcine Vaccines Sales by Company (2019-2024) & (M Units)
Table 19. Global Porcine Vaccines Sales Market Share by Company (2019-2024)
Table 20. Global Porcine Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Porcine Vaccines Revenue Market Share by Company (2019-2024)
Table 22. Global Porcine Vaccines Sale Price by Company (2019-2024) & (USD/K Unit)
Table 23. Key Manufacturers Porcine Vaccines Producing Area Distribution and Sales Area
Table 24. Players Porcine Vaccines Products Offered
Table 25. Porcine Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Porcine Vaccines Sales by Geographic Region (2019-2024) & (M Units)
Table 29. Global Porcine Vaccines Sales Market Share Geographic Region (2019-2024)
Table 30. Global Porcine Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Porcine Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Porcine Vaccines Sales by Country/Region (2019-2024) & (M Units)
Table 33. Global Porcine Vaccines Sales Market Share by Country/Region (2019-2024)
Table 34. Global Porcine Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Porcine Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Porcine Vaccines Sales by Country (2019-2024) & (M Units)
Table 37. Americas Porcine Vaccines Sales Market Share by Country (2019-2024)
Table 38. Americas Porcine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Porcine Vaccines Revenue Market Share by Country (2019-2024)
Table 40. Americas Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 41. Americas Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 42. APAC Porcine Vaccines Sales by Region (2019-2024) & (M Units)
Table 43. APAC Porcine Vaccines Sales Market Share by Region (2019-2024)
Table 44. APAC Porcine Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Porcine Vaccines Revenue Market Share by Region (2019-2024)
Table 46. APAC Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 47. APAC Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 48. Europe Porcine Vaccines Sales by Country (2019-2024) & (M Units)
Table 49. Europe Porcine Vaccines Sales Market Share by Country (2019-2024)
Table 50. Europe Porcine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Porcine Vaccines Revenue Market Share by Country (2019-2024)
Table 52. Europe Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 53. Europe Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 54. Middle East & Africa Porcine Vaccines Sales by Country (2019-2024) & (M Units)
Table 55. Middle East & Africa Porcine Vaccines Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Porcine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Porcine Vaccines Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Porcine Vaccines Sales by Type (2019-2024) & (M Units)
Table 59. Middle East & Africa Porcine Vaccines Sales by Application (2019-2024) & (M Units)
Table 60. Key Market Drivers & Growth Opportunities of Porcine Vaccines
Table 61. Key Market Challenges & Risks of Porcine Vaccines
Table 62. Key Industry Trends of Porcine Vaccines
Table 63. Porcine Vaccines Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Porcine Vaccines Distributors List
Table 66. Porcine Vaccines Customer List
Table 67. Global Porcine Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 68. Global Porcine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Porcine Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 70. Americas Porcine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Porcine Vaccines Sales Forecast by Region (2025-2030) & (M Units)
Table 72. APAC Porcine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Porcine Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 74. Europe Porcine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Porcine Vaccines Sales Forecast by Country (2025-2030) & (M Units)
Table 76. Middle East & Africa Porcine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Porcine Vaccines Sales Forecast by Type (2025-2030) & (M Units)
Table 78. Global Porcine Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Porcine Vaccines Sales Forecast by Application (2025-2030) & (M Units)
Table 80. Global Porcine Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Merck Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Porcine Vaccines Product Portfolios and Specifications
Table 83. Merck Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. Boehringer Ingelheim Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. Boehringer Ingelheim Porcine Vaccines Product Portfolios and Specifications
Table 88. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Jinyu Bio-Technology Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Jinyu Bio-Technology Porcine Vaccines Product Portfolios and Specifications
Table 93. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 94. Jinyu Bio-Technology Main Business
Table 95. Jinyu Bio-Technology Latest Developments
Table 96. CAHIC Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. CAHIC Porcine Vaccines Product Portfolios and Specifications
Table 98. CAHIC Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 99. CAHIC Main Business
Table 100. CAHIC Latest Developments
Table 101. Tecon Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Tecon Porcine Vaccines Product Portfolios and Specifications
Table 103. Tecon Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 104. Tecon Main Business
Table 105. Tecon Latest Developments
Table 106. Zoetis Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Zoetis Porcine Vaccines Product Portfolios and Specifications
Table 108. Zoetis Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 109. Zoetis Main Business
Table 110. Zoetis Latest Developments
Table 111. Ceva Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Ceva Porcine Vaccines Product Portfolios and Specifications
Table 113. Ceva Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 114. Ceva Main Business
Table 115. Ceva Latest Developments
Table 116. Hile Bio Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Hile Bio Porcine Vaccines Product Portfolios and Specifications
Table 118. Hile Bio Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 119. Hile Bio Main Business
Table 120. Hile Bio Latest Developments
Table 121. Chopper Biology Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. Chopper Biology Porcine Vaccines Product Portfolios and Specifications
Table 123. Chopper Biology Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 124. Chopper Biology Main Business
Table 125. Chopper Biology Latest Developments
Table 126. WINSUN Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. WINSUN Porcine Vaccines Product Portfolios and Specifications
Table 128. WINSUN Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 129. WINSUN Main Business
Table 130. WINSUN Latest Developments
Table 131. Hipra Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Hipra Porcine Vaccines Product Portfolios and Specifications
Table 133. Hipra Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 134. Hipra Main Business
Table 135. Hipra Latest Developments
Table 136. Ringpu Biology Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. Ringpu Biology Porcine Vaccines Product Portfolios and Specifications
Table 138. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 139. Ringpu Biology Main Business
Table 140. Ringpu Biology Latest Developments
Table 141. DHN Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. DHN Porcine Vaccines Product Portfolios and Specifications
Table 143. DHN Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 144. DHN Main Business
Table 145. DHN Latest Developments
Table 146. CAVAC Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. CAVAC Porcine Vaccines Product Portfolios and Specifications
Table 148. CAVAC Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 149. CAVAC Main Business
Table 150. CAVAC Latest Developments
Table 151. Virbac Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. Virbac Porcine Vaccines Product Portfolios and Specifications
Table 153. Virbac Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 154. Virbac Main Business
Table 155. Virbac Latest Developments
Table 156. HVRI Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. HVRI Porcine Vaccines Product Portfolios and Specifications
Table 158. HVRI Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 159. HVRI Main Business
Table 160. HVRI Latest Developments
Table 161. Bioveta Basic Information, Porcine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. Bioveta Porcine Vaccines Product Portfolios and Specifications
Table 163. Bioveta Porcine Vaccines Sales (M Units), Revenue ($ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
Table 164. Bioveta Main Business
Table 165. Bioveta Latest Developments
LIST OF FIGURES
Figure 1. Picture of Porcine Vaccines
Figure 2. Porcine Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Porcine Vaccines Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Porcine Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Porcine Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CSF Vaccines
Figure 10. Product Picture of FMD Vaccines
Figure 11. Product Picture of Porcine Circovirus Vaccines
Figure 12. Product Picture of PRRS Vaccines
Figure 13. Product Picture of Other
Figure 14. Global Porcine Vaccines Sales Market Share by Type in 2023
Figure 15. Global Porcine Vaccines Revenue Market Share by Type (2019-2024)
Figure 16. Porcine Vaccines Consumed in Government Tender
Figure 17. Global Porcine Vaccines Market: Government Tender (2019-2024) & (M Units)
Figure 18. Porcine Vaccines Consumed in Market Sales
Figure 19. Global Porcine Vaccines Market: Market Sales (2019-2024) & (M Units)
Figure 20. Global Porcine Vaccines Sales Market Share by Application (2023)
Figure 21. Global Porcine Vaccines Revenue Market Share by Application in 2023
Figure 22. Porcine Vaccines Sales Market by Company in 2023 (M Units)
Figure 23. Global Porcine Vaccines Sales Market Share by Company in 2023
Figure 24. Porcine Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Porcine Vaccines Revenue Market Share by Company in 2023
Figure 26. Global Porcine Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Porcine Vaccines Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Porcine Vaccines Sales 2019-2024 (M Units)
Figure 29. Americas Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 30. APAC Porcine Vaccines Sales 2019-2024 (M Units)
Figure 31. APAC Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 32. Europe Porcine Vaccines Sales 2019-2024 (M Units)
Figure 33. Europe Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Porcine Vaccines Sales 2019-2024 (M Units)
Figure 35. Middle East & Africa Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Americas Porcine Vaccines Sales Market Share by Country in 2023
Figure 37. Americas Porcine Vaccines Revenue Market Share by Country in 2023
Figure 38. Americas Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 39. Americas Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 40. United States Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Porcine Vaccines Sales Market Share by Region in 2023
Figure 45. APAC Porcine Vaccines Revenue Market Share by Regions in 2023
Figure 46. APAC Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 47. APAC Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 48. China Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Porcine Vaccines Sales Market Share by Country in 2023
Figure 56. Europe Porcine Vaccines Revenue Market Share by Country in 2023
Figure 57. Europe Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 58. Europe Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 59. Germany Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Porcine Vaccines Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Porcine Vaccines Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Porcine Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Porcine Vaccines
Figure 75. Industry Chain Structure of Porcine Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Porcine Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Porcine Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Porcine Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Porcine Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Porcine Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Porcine Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Porcine Vaccines
Figure 2. Porcine Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Porcine Vaccines Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Porcine Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Porcine Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CSF Vaccines
Figure 10. Product Picture of FMD Vaccines
Figure 11. Product Picture of Porcine Circovirus Vaccines
Figure 12. Product Picture of PRRS Vaccines
Figure 13. Product Picture of Other
Figure 14. Global Porcine Vaccines Sales Market Share by Type in 2023
Figure 15. Global Porcine Vaccines Revenue Market Share by Type (2019-2024)
Figure 16. Porcine Vaccines Consumed in Government Tender
Figure 17. Global Porcine Vaccines Market: Government Tender (2019-2024) & (M Units)
Figure 18. Porcine Vaccines Consumed in Market Sales
Figure 19. Global Porcine Vaccines Market: Market Sales (2019-2024) & (M Units)
Figure 20. Global Porcine Vaccines Sales Market Share by Application (2023)
Figure 21. Global Porcine Vaccines Revenue Market Share by Application in 2023
Figure 22. Porcine Vaccines Sales Market by Company in 2023 (M Units)
Figure 23. Global Porcine Vaccines Sales Market Share by Company in 2023
Figure 24. Porcine Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Porcine Vaccines Revenue Market Share by Company in 2023
Figure 26. Global Porcine Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Porcine Vaccines Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Porcine Vaccines Sales 2019-2024 (M Units)
Figure 29. Americas Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 30. APAC Porcine Vaccines Sales 2019-2024 (M Units)
Figure 31. APAC Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 32. Europe Porcine Vaccines Sales 2019-2024 (M Units)
Figure 33. Europe Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Porcine Vaccines Sales 2019-2024 (M Units)
Figure 35. Middle East & Africa Porcine Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Americas Porcine Vaccines Sales Market Share by Country in 2023
Figure 37. Americas Porcine Vaccines Revenue Market Share by Country in 2023
Figure 38. Americas Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 39. Americas Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 40. United States Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Porcine Vaccines Sales Market Share by Region in 2023
Figure 45. APAC Porcine Vaccines Revenue Market Share by Regions in 2023
Figure 46. APAC Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 47. APAC Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 48. China Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Porcine Vaccines Sales Market Share by Country in 2023
Figure 56. Europe Porcine Vaccines Revenue Market Share by Country in 2023
Figure 57. Europe Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 58. Europe Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 59. Germany Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Porcine Vaccines Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Porcine Vaccines Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Porcine Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Porcine Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Porcine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Porcine Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Porcine Vaccines
Figure 75. Industry Chain Structure of Porcine Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Porcine Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Porcine Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Porcine Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Porcine Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Porcine Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Porcine Vaccines Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Soft Tissue Dissection Device Market Growth 2025-2031
US$ 3,660.00
January 2025
80 pages
Global Rituxan (rituximab) Drug Market Growth 2024-2030
US$ 3,660.00
March 2024
81 pages
Global Tuberculosis (TB) Detection Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
82 pages
Global Veterinary Orthoses Market Growth 2024-2030
US$ 3,660.00
September 2024
114 pages
Global Auto Titrators Market Growth 2023-2029
US$ 3,660.00
February 2023
117 pages
